Ann: Novogen Receives R&D Tax Incentive Cash Refund of $2.8M, page-39

First 39 Last

Share
Profile

Follow
Metrader

542 Posts.

202

17/03/16

13:34

Post #: 17300028
Share

Originally posted by Samscout ↑

I think this like good news to me re the tox results - can't see why you would present at a conference if it was going to be bad news.

I think I finally get what's going on - my understanding is that NRT is in partnership with Yale re Cantrixil and Gil Mor works for Yale. This is just a guess but I suspect that part of the price for being in partnership with such an esteemed research institution is that they get bragging rights - given a lot of scientists work for peanuts - the part where they deliver their findings is probably the highlight of their careers. Furthermore as a matter of process, the ability to retain and control the release of research data is very important - otherwise you run the risk of getting corporate cowboys making premature or inaccurate media releases to pump share prices. That's not a dig at GK by the way - it just seems to me what's going on - especially in light of last years retracted announcement.

Arguably this does run up against continuous disclosure but I suspect that NRT are within guidelines here as disclosing the information is a breach of contract with Yale which would then be a breach of the law as per Pb's post above about disclosure rules - i.e. NRT has a contractual obligation to let Yale release the research obligation.

I think todays announcement is telling us all we need to know - for me personally anyway as I am not a scientist - the number of milligrams per whatever means jack to me - knowing the drug is compliant with the right authorities is what I am looking for.

I'm starting to feel good about what's going on again for the first time in a long time. On the assumption that the news is good news on April 15 lets just hope that this drug and the company gets the attention it then deserves.

GLTA/IMHO

Expand

The real reason is ..... On the 15th of April 2015 the share price peaked at 43c. Quite simply, the Board has stayed silent as they have been waiting for that date in 2016 so they can give us a nice anniversary present.
Kiddin'. I'm with you on this, Samscout. Makes sense to let the academic egos have their day. To be sure, to be sure.

NRT Price at posting: 11.3¢ Sentiment: Hold Disclosure: Held
5 Upvote

0 Great analysis

Reply

Top Stories

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

TLG

Talga Group wins key permit for flagship graphite mine in Sweden

SWP

Swoop lobs $18M offer at microcap telecom Vonex – in which it holds 19.9%

What's causing the cost-of-living crisis, and how to navigate it

M4M

Macro, Norden set up transport solutions initiative for West Pilbara

MTH

Mithril's drilling in Mexico picks up silver at 997g/t, gold at 28g/t

SNX

Sierra Nevada raises $2M for silver exploration at Blackhawk

Week 42 Wrap: HotCopper's top picks; new ASX 200 record; world yawns at war

IRX

InhaleRX snags $38.5M in funding from VC biotech funder Clendon

NVU

Nanoveu surges 10% after benchmark testing for new AI chip begins